Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Common Stock · CUSIP: 921659108
Event date: 2026-09-30
- Filing-level shares
- 3,587,013
- Percent of class
- 5.9%
- BlackRock Portfolio Management LLC
Shares: 3,587,013 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-26-001132
- Form type
- SCHEDULE 13G
- Filer
- BlackRock Portfolio Management LLC
- CIK
- CIK 2052113
- Filed
- Oct 27, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership